![](/images/general/no_picture/200_user.png)
Melur Ramakrishnaiah
Examiner (ID: 1524, Phone: (571)272-8098 , Office: P/2656 )
Most Active Art Unit | 2656 |
Art Unit(s) | 2614, 2643, 2656, 2651, 2691, 2743 |
Total Applications | 3169 |
Issued Applications | 2675 |
Pending Applications | 81 |
Abandoned Applications | 413 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7456472
[patent_doc_number] => 20040197273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Suspension aerosol formulations'
[patent_app_type] => new
[patent_app_number] => 10/820817
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7479
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820817
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820817 | Suspension aerosol formulations | Apr 8, 2004 | Abandoned |
Array
(
[id] => 5784477
[patent_doc_number] => 20060204568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Oral pharmaceutical preparation for proton pump antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/551943
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10548
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204568.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551943
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551943 | Oral pharmaceutical preparation for proton pump antagonists | Apr 7, 2004 | Abandoned |
Array
(
[id] => 7033158
[patent_doc_number] => 20050031667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Implantable polymeric device for sustained release of dopamine agonist'
[patent_app_type] => utility
[patent_app_number] => 10/815481
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6474
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815481
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815481 | Implantable polymeric device for sustained release of dopamine agonist | Mar 30, 2004 | Abandoned |
Array
(
[id] => 7345826
[patent_doc_number] => 20040247670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Temperature sensitive polymers'
[patent_app_type] => new
[patent_app_number] => 10/804302
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8951
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20040247670.pdf
[firstpage_image] =>[orig_patent_app_number] => 10804302
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/804302 | Temperature sensitive polymers | Mar 17, 2004 | Issued |
Array
(
[id] => 7147984
[patent_doc_number] => 20040170599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Chemotherapeutic compositions'
[patent_app_type] => new
[patent_app_number] => 10/792867
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5855
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10792867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/792867 | Chemotherapeutic compositions | Mar 4, 2004 | Issued |
Array
(
[id] => 6942511
[patent_doc_number] => 20050194559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Crosslinkable hydrophilic materials from reactive oligomers having pendent unsaturated groups'
[patent_app_type] => utility
[patent_app_number] => 10/792238
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12148
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20050194559.pdf
[firstpage_image] =>[orig_patent_app_number] => 10792238
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/792238 | Crosslinkable hydrophilic materials from reactive oligomers having pendent unsaturated groups | Mar 1, 2004 | Issued |
Array
(
[id] => 7436636
[patent_doc_number] => 20040185100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin'
[patent_app_type] => new
[patent_app_number] => 10/789174
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7258
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789174
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789174 | Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin | Feb 25, 2004 | Issued |
Array
(
[id] => 7419294
[patent_doc_number] => 20040228883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Prepackaged aqueous pharmaceutical formulation for the treatment of cardiac conditions containing at least two different active agents and method of formulation'
[patent_app_type] => new
[patent_app_number] => 10/785169
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2447
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20040228883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785169
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785169 | Prepackaged aqueous pharmaceutical formulation for the treatment of cardiac conditions containing at least two different active agents and method of formulation | Feb 22, 2004 | Abandoned |
Array
(
[id] => 7090324
[patent_doc_number] => 20050010170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'IMPLANTABLE MEDICAL DEVICE WITH BENEFICIAL AGENT CONCENTRATION GRADIENT'
[patent_app_type] => utility
[patent_app_number] => 10/777283
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6181
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20050010170.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777283 | IMPLANTABLE MEDICAL DEVICE WITH BENEFICIAL AGENT CONCENTRATION GRADIENT | Feb 10, 2004 | Abandoned |
Array
(
[id] => 7275146
[patent_doc_number] => 20040234597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'pH triggered site specific targeted controlled drug delivery system for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/769008
[patent_app_country] => US
[patent_app_date] => 2004-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11520
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10769008
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/769008 | pH triggered site specific targeted controlled drug delivery system for the treatment of cancer | Jan 29, 2004 | Abandoned |
Array
(
[id] => 7276920
[patent_doc_number] => 20040236371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Light-activated adhesive composite, system, and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/757818
[patent_app_country] => US
[patent_app_date] => 2004-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17831
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20040236371.pdf
[firstpage_image] =>[orig_patent_app_number] => 10757818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/757818 | Light-activated adhesive composite, system, and methods of use thereof | Jan 14, 2004 | Issued |
Array
(
[id] => 662158
[patent_doc_number] => 07101538
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-05
[patent_title] => 'Polyesteramine ingredient and use of same'
[patent_app_type] => utility
[patent_app_number] => 10/748597
[patent_app_country] => US
[patent_app_date] => 2003-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3121
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10748597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/748597 | Polyesteramine ingredient and use of same | Dec 29, 2003 | Issued |
Array
(
[id] => 7249930
[patent_doc_number] => 20050142097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Multiple active drug resin conjugate'
[patent_app_type] => utility
[patent_app_number] => 10/747509
[patent_app_country] => US
[patent_app_date] => 2003-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5372
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10747509
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/747509 | Multiple active drug resin conjugate | Dec 28, 2003 | Abandoned |
Array
(
[id] => 7250476
[patent_doc_number] => 20050142185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Softgel formulations of bisphosphonates bone resorption inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/745496
[patent_app_country] => US
[patent_app_date] => 2003-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6989
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10745496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/745496 | Softgel formulations of bisphosphonates bone resorption inhibitors | Dec 28, 2003 | Abandoned |
Array
(
[id] => 5865136
[patent_doc_number] => 20060099266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Slow release formulation of clarithromycin'
[patent_app_type] => utility
[patent_app_number] => 10/540448
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2357
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540448 | Slow release formulation of clarithromycin | Dec 21, 2003 | Abandoned |
Array
(
[id] => 6996245
[patent_doc_number] => 20050136023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Electrically conductive adhesive hydrogels with a thermally activated chemical initiator'
[patent_app_type] => utility
[patent_app_number] => 10/739514
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8904
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10739514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/739514 | Electrically conductive adhesive hydrogels with a thermally activated chemical initiator | Dec 17, 2003 | Abandoned |
Array
(
[id] => 7098689
[patent_doc_number] => 20050131148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Reactive hydrophilic oligomers'
[patent_app_type] => utility
[patent_app_number] => 10/732715
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12378
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131148.pdf
[firstpage_image] =>[orig_patent_app_number] => 10732715
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/732715 | Reactive hydrophilic oligomers | Dec 9, 2003 | Issued |
Array
(
[id] => 7468251
[patent_doc_number] => 20040121001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Orally adminstrable opioid formulations having extended duration of effect'
[patent_app_type] => new
[patent_app_number] => 10/731678
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9358
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10731678
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/731678 | Orally adminstrable opioid formulations having extended duration of effect | Dec 7, 2003 | Abandoned |
Array
(
[id] => 7425689
[patent_doc_number] => 20040161468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Stabilization of aromatic active principles using aromatic polymers'
[patent_app_type] => new
[patent_app_number] => 10/726557
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4212
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726557
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726557 | Stabilization of aromatic active principles using aromatic polymers | Dec 3, 2003 | Abandoned |
Array
(
[id] => 6917706
[patent_doc_number] => 20050095267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Nanoparticle-based controlled release polymer coatings for medical implants'
[patent_app_type] => utility
[patent_app_number] => 10/727894
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15709
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727894
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727894 | Nanoparticle-based controlled release polymer coatings for medical implants | Dec 2, 2003 | Abandoned |